当前位置:首页 - 行情中心 - 国际医学(000516) - 财务分析

国际医学

(000516)

  

流通市值:89.30亿  总市值:90.68亿
流通股本:22.05亿   总股本:22.39亿

国际医学(000516)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.74亿元,每股收益-0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益293360.04万元,未分配利润-34144.54万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产949744.07万元,负债656384.03万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入969,398,246.514,074,514,927.552,995,437,323.472,034,307,690.46
营业总成本1,046,750,589.274,523,904,141.743,379,382,067.182,279,057,237.69
其他经营收益
营业利润-71,163,831-400,439,519.31-360,502,200.22-211,663,325.64
利润总额-71,127,241.53-400,297,695.35-360,210,877.21-213,131,740.97
净利润-73,671,879.9-421,027,140.03-374,029,115.97-218,312,970.23
每股收益
其他综合收益----
综合收益总额-73,671,879.9-421,027,140.03-374,029,115.97-218,312,970.23
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,041,889,271.991,131,406,707.171,150,867,696.81,185,953,128.62
非流动资产:
非流动资产合计8,455,551,450.848,579,646,677.038,639,788,816.098,819,558,543.5
资产总计9,497,440,722.839,711,053,384.29,790,656,512.8910,005,511,672.12
流动负债:
流动负债合计4,217,033,371.744,452,623,490.14,229,596,306.024,210,763,756.21
非流动负债:
非流动负债合计2,346,806,913.22,251,157,576.312,506,789,865.022,584,771,936.46
负债合计6,563,840,284.946,703,781,066.416,736,386,171.046,795,535,692.67
所有者权益(或股东权益):
归属于母公司股东权益合计3,269,820,226.863,318,161,776.343,337,580,628.583,466,264,833.36
股东权益合计2,933,600,437.893,007,272,317.793,054,270,341.853,209,975,979.45
负债和股东权益合计9,497,440,722.839,711,053,384.29,790,656,512.8910,005,511,672.12
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,026,418,902.814,319,228,091.843,200,253,779.932,235,548,073.73
经营活动现金流出小计776,967,461.493,042,758,570.072,279,249,924.381,643,006,109.68
经营活动产生的现金流量净额249,451,441.321,276,469,521.77921,003,855.55592,541,964.05
投资活动产生的现金流量:
投资活动现金流入小计19,083,432136,355,396.0188,216,010.8988,210,678.89
投资活动现金流出小计58,324,330.78263,467,565.06235,376,144.3207,482,673.01
投资活动产生的现金流量净额-39,240,898.78-127,112,169.05-147,160,133.41-119,271,994.12
筹资活动产生的现金流量:
筹资活动现金流入小计344,350,000493,010,000266,310,000203,010,000
筹资活动现金流出小计600,865,577.661,801,794,328.321,345,642,955.84959,029,573.49
筹资活动产生的现金流量净额-256,515,577.66-1,308,784,328.32-1,079,332,955.84-756,019,573.49
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-46,305,035.12-159,426,975.6-305,489,233.7-282,749,603.56
期末现金及现金等价物余额342,829,992.66389,135,027.78243,072,769.68265,812,399.82
补充资料:
现金及现金等价物的净增加额--159,426,975.6--282,749,603.56
最新报告期:2026-05-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
东海证券杜永宏-0.10-0.06-0.022026-05-28
中信证券宋硕,陈竹,沈睦钧-0.07-0.040.012026-05-27
中信建投华冉,王在存,贺菊颖-0.05-0.010.022026-05-20
西南证券杜向阳-0.040.020.052026-04-29
TOP↑